相关实验视频
Updated: Jul 19, 2026
11:29
A Modified Method for Heterotopic Mouse Heart Transplantion
Published on: June 23, 2014
通过同质的心脏外移性心脏基因转移对心脏电生理学的有针对性的修改
Kan Kikuchi1, Amy D McDonald, Tetsuo Sasano
1Johns Hopkins University School of Medicine, Baltimore, Md 21205, USA.
Circulation
|January 12, 2005
概括
这项研究引入了一种新的心房基因转移方法,使用心上应用和轻度试化进行安全有效的基因传递. 这种技术实现了完整的移动基因转移,为治疗心房和其他心脏病提供了潜在的治疗机会.
科学领域:
- 心血管研究研究心血管研究
- 基因治疗 基因治疗
- 分子心脏病学分子心脏病学
背景情况:
- 心肌基因转移仍然是一个重大挑战,现有的方法缺乏临床翻译性,尚未实现心房特异性传递.
- 之前在小哺乳动物中进行室内基因传递的尝试已经显示出临床适用性的局限性.
- 目前还没有成功报告心房特异性基因转移,这凸显了当前治疗策略中的差距.
研究的目的:
- 开发一种同质有效的心房基因转移方法.
- 为了研究腺病毒载体与波洛克萨默凝和轻度试化结合的直接表心应用的可行性.
- 评估这种新型基因转移技术在猪心房中的安全性和有效性.
主要方法:
- 编码埃舍里希亚大肠杆菌β-galactosidase的重组腺病毒直接在猪心脏上应用.
- 使用波洛克萨默凝来增强病毒接触时间和轻微的试化,以改善心肌透.
- 研究了不同的波洛克萨默度和素水平,以及安全性评估.
主要成果:
- 使用稀释素的"涂装"方法,实现了完整的穿越性心房基因转移.
- 单独使用Poloxamer凝就会导致表面性心脏表皮基因转移,透率最小.
- HERG-G628S基因转移延长了心房动作潜力的持续时间和耐火期,而不会影响心室电生理学;心房功能和直径在术后基本不受影响.
结论:
- 已经证明了一种新而完整的脑膜外转移基因转移方法 ("绘画").
- 这种技术有可能适应用于基因治疗的其他组织点.
- 通过这种方法应用功能性蛋白质可以为心房动和鼻节功能障碍提供治疗解决方案.
相关概念视频
01:28Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...